The EIF2A Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from A-549 human lung adenocarcinoma cells, featuring targeted disruption of the EIF2A gene. This heterogeneous knockout pool provides a functional loss-of-function model for investigating EIF2A-dependent translation initiation without single-cell cloning.
A-549 is an epithelial cell line originating from human lung adenocarcinoma, widely used in cancer biology and stress response research. These cells express key components of the integrated stress response, including the kinases PERK (EIF2AK3) and GCN2 (EIF2AK4), and serve as a relevant model for studying translation control in tumor cells under stress conditions such as nutrient deprivation or hypoxia.
EIF2A is a translation initiation factor that delivers initiator Met-tRNAi to the 40S ribosomal subunit in a GTP-independent manner, acting as an alternative initiation pathway when canonical eIF2 function is inhibited. Under stress conditions (e.g., ER stress, amino acid deprivation), upstream kinases including PERK (EIF2AK3), GCN2 (EIF2AK4), PKR, and HRI phosphorylate eIF2?? (EIF2S1), leading to suppression of the eIF2?CGTP?CMet-tRNAi ternary complex. EIF2A bypasses this block by directly interacting with the 40S ribosomal subunit, Met-tRNAi, and the eIF3 complex, and selectively promotes translation of mRNAs containing uORFs or IRES elements, such as ATF4, DDIT3, and PPP1R15A. Additionally, EIF2A associates with stress granule proteins like G3BP1, connecting it to RNA metabolism under stress. Through these interactions, EIF2A integrates upstream stress signals to drive a gene expression program critical for cellular adaptation and survival.
In A-549 lung adenocarcinoma cells, EIF2A disruption is predicted to impair the translation of stress-responsive uORF-containing mRNAs, thereby attenuating the cellular stress adaptation response. This polyclonal knockout model enables detailed investigation of how EIF2A contributes to tumor cell survival, proliferation, and chemoresistance under stressful conditions such as hypoxia or nutrient limitation. Additionally, as A-549 cells support replication of certain viruses, the model permits examination of EIF2A??s role in IRES-mediated translation of viral RNAs, offering insights into host?Cpathogen interactions.
Key applications include polysome profiling and luciferase reporter assays with uORF/IRES elements to monitor translation under stress conditions (e.g., tunicamycin or arsenite treatment). Western blotting for protein synthesis markers, viability assays, and translatome-wide RNA-seq can further elucidate EIF2A-dependent mRNA subsets. This tool is valuable for drug target validation in stress-related disorders. For inquiries, contact Ascent Research.
